106 related articles for article (PubMed ID: 34665094)
1. Legal Challenges Underlying COVID-19 Vaccinations.
Hodge JG; Piatt JL; Barraza L; Freed R; Ghaith S; Wells N
J Law Med Ethics; 2021; 49(3):495-499. PubMed ID: 34665094
[TBL] [Abstract][Full Text] [Related]
2. Silent Consequences of COVID-19: Why It's Critical to Recover Routine Vaccination Rates Through Equitable Vaccine Policies and Practices.
Skolnik A; Bhatti A; Larson A; Mitrovich R
Ann Fam Med; 2021; 19(6):527-531. PubMed ID: 34376387
[TBL] [Abstract][Full Text] [Related]
3. The COVID-19 vaccination campaign in Bhutan: strategy and enablers.
Tsheten T; Tenzin P; Clements ACA; Gray DJ; Ugyel L; Wangdi K
Infect Dis Poverty; 2022 Jan; 11(1):6. PubMed ID: 34986883
[TBL] [Abstract][Full Text] [Related]
4. Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States.
Gupta S; Cantor J; Simon KI; Bento AI; Wing C; Whaley CM
Health Aff (Millwood); 2021 Sep; 40(9):1465-1472. PubMed ID: 34406840
[TBL] [Abstract][Full Text] [Related]
5. [Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].
Dabanch J; Bastías M; Endeiza ML; Díaz E; Inostroza J; Cerda J; Santillana S; Rodríguez J; González C; Rodríguez M; Pizarro A
Rev Chilena Infectol; 2021 Apr; 38(2):185-188. PubMed ID: 34184708
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
Hunter CM; Chou WS; Webb Hooper M
Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
[TBL] [Abstract][Full Text] [Related]
7. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
[TBL] [Abstract][Full Text] [Related]
8. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
[No Abstract] [Full Text] [Related]
9. Anaphylaxis is a rare reaction in COVID-19 vaccination.
Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.
Dalal RS; McClure E; Marcus J; Winter RW; Hamilton MJ; Allegretti JR
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1730-1732.e2. PubMed ID: 33549869
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System.
Weitzman ER; Sherman AC; Levy O
Front Public Health; 2021; 9():695807. PubMed ID: 34336774
[TBL] [Abstract][Full Text] [Related]
12. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
[TBL] [Abstract][Full Text] [Related]
13. Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.
Hajissa K; Mussa A
Hum Vaccin Immunother; 2021 Aug; 17(8):2445-2447. PubMed ID: 33830862
[TBL] [Abstract][Full Text] [Related]
14. [Do we need a pediatric COVID-19 vaccine?].
Eberhardt CS; Siegrist CA
Rev Med Suisse; 2021 Feb; 17(726):353-357. PubMed ID: 33599412
[TBL] [Abstract][Full Text] [Related]
15. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.
Soy M; Keser G; Atagunduz P; Mutlu MY; Gunduz A; Koybaşi G; Bes C
Clin Rheumatol; 2021 Sep; 40(9):3533-3545. PubMed ID: 33751280
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
17. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
Salzman MB; Huang CW; O'Brien CM; Castillo RD
Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
[TBL] [Abstract][Full Text] [Related]
18. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.
Body A; Ahern E; Segelov E
Intern Med J; 2021 Oct; 51(10):1760. PubMed ID: 34664360
[No Abstract] [Full Text] [Related]
20. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
